BioGaia AB (CHIX:BIOGBS) Beginning Cash Position: kr872 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CHIX:BIOGBS BioGaia AB CHIX:BIOGBS
92 GF Score
Price kr120.20
GF Value kr136.19
! 1 Warning Sign
View Full Analysis

What is BioGaia AB Beginning Cash Position?

BioGaia AB CHIX:BIOGBS 92 Beginning Cash Position is kr872 Mil as of Jun. 2026. GuruFocus rates CHIX:BIOGBS with a GF Score™ of 92/100 and a GF Value™ of kr136.19. The stock has 1 warning sign investors should review.

BioGaia AB's Beginning Cash Position for the quarter that ended in Jun. 2026 was kr872 Mil.

BioGaia AB's quarterly Beginning Cash Position increased from Dec. 2025 (kr728 Mil) to Mar. 2026 (kr801 Mil) and increased from Mar. 2026 (kr801 Mil) to Jun. 2026 (kr872 Mil).

BioGaia AB's annual Beginning Cash Position increased from Dec. 2023 (kr1,488 Mil) to Dec. 2024 (kr1,544 Mil) but then declined from Dec. 2024 (kr1,544 Mil) to Dec. 2025 (kr1,224 Mil).

BioGaia AB Beginning Cash Position Related Terms

BioGaia AB Beginning Cash Position Historical Data

* Premium members only.

The historical data trend for BioGaia AB's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BioGaia AB Beginning Cash Position Chart

BioGaia AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beginning Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,467.88 1,484.68 1,488.37 1,544.19 1,223.98

BioGaia AB Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Beginning Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,249.30 622.34 728.10 801.31 871.78
CHIX:BIOGBS
92GF Score
BioGaia AB CHIX:BIOGBS
Beginning Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

BioGaia AB Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

What does a Beginning Cash Position of kr872 Mil mean?
BioGaia AB (CHIX:BIOGBS) has a Beginning Cash Position of kr872 Mil as of Jun. 2026. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on BioGaia AB and its competitors.
Is BioGaia AB's Beginning Cash Position too high?
BioGaia AB's current Beginning Cash Position is kr872 Mil. Overall, BioGaia AB has a GF Score™ of 92/100, reflecting its overall financial health beyond just this single metric.
How does BioGaia AB's Beginning Cash Position compare to ZTS?
BioGaia AB's Beginning Cash Position of kr872 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beginning Cash Position for a Drug Manufacturers company?
A good Beginning Cash Position depends on the Drug Manufacturers industry context. However, Beginning Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beginning Cash Position mean?
A high Beginning Cash Position can signal that a stock is expensive relative to its fundamentals. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on BioGaia AB and its competitors. BioGaia AB's current Beginning Cash Position is kr872 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BioGaia AB stock overvalued right now?
BioGaia AB (CHIX:BIOGBS) has a current Beginning Cash Position of kr872 Mil. The stock's GF Value™ is kr136.19, compared to a current price of kr120.20 — trading 11.7% below its estimated fair value. The current Beginning Cash Position is kr872 Mil. BioGaia AB's overall GF Score™ is 92/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beginning Cash Position calculated?
Beginning Cash Position is calculated from a company's financial statements. For BioGaia AB (CHIX:BIOGBS), the current Beginning Cash Position is kr872 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is BioGaia AB (CHIX:BIOGBS) Overvalued in 2026?

Based on GuruFocus' analysis, BioGaia AB stock appears to be undervalued. The current stock price of kr120.20 is trading 11.7% below its estimated GF Value™ of kr136.19.

Key valuation signals for CHIX:BIOGBS:

  • Beginning Cash Position: kr872 Mil
  • GF Value™: kr136.19 vs. price of kr120.20 (11.7% below fair value)
  • GF Score™: 92/100 with 1 warning sign

No single metric tells the full story. See the CHIX:BIOGBS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

BioGaia AB Business Description

Address Kungsbroplan 3A, Stockholm, SWE, SE-112 27
BioGaia AB is a healthcare company engaged in developing, marketing, and selling probiotic products. The company has three operating segments; Paediatrics segment includes drops, gut health tablets, oral rehydration solution (ORS) and cultures to be used as ingredients in licensee products such as infant formula, as well as royalty revenue for pediatric products, Adult Health segment includes gut health tablets, oral health lozenges and cultures as an ingredient in a licensee's dairy products, and Other segment include royalties in respect of development projects, revenue from packaging solutions in the subsidiary CapAble, etc. Geographically, it operates in three regions: EMEA, the Americas, and APAC (Asia-Pacific, Australia, and New Zealand).
92GF Score

Get the complete analysis for CHIX:BIOGBS

Beginning Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr120.20
Price
kr136.19
GF Value